|
|
| journal of pharmaceutical sciences | 8 |  | 5.00 |
| fda.moph.go.th | 5 | | 3.12 |
| ¡ÒõÃǨàÍ¡Åѡɳì¾×ªÊÁعä¾Ã | 4 | | 2.50 |
| ÁÍ¡. ¡ÃдÒÉà¢Õ¹ | 3 | | 1.88 |
| à¡Å×Íä¹äµÃ·ì | 3 | | 1.88 |
| Áҵðҹ¹éÓ´×èÁºÃèآǴ | 2 | | 1.25 |
| §Ò¹ÇԨѾĵԡÃÃÁ¡ÒÃãªéÂÒã¹¼Ùé»èÇÂàºÒËÇÒ¹ | 2 | | 1.25 |
| Í. | 2 | | 1.25 |
| à·¤¹Ô¤¡ÒÃÍèÒ¹ÀÒÉÒÍѧ¡ÄÉà¾×èͤÇÒÁà¢éÒ㨠| 2 | | 1.25 |
| âç¾ÂÒºÒÅÍÀÑÂÀÙàºÈà §Ò¹ºÃÔËÒÃàǪÀѳ±ì | 2 | | 1.25 |
| Ẻ»ÃÐàÁÔ¹¤ÇÒÁàËÁÒÐÊÁ㹡ÒÃãªéÂÒ ceftazidime | 2 | | 1.25 |
| ÂÒ | 2 | | 1.25 |
| â»Ãá¡ÃÁ¨ÔµºÓºÑ´ in bipolar disorder | 2 | | 1.25 |
| ÇÔ·Â ºÃÔ¡Òà ʶҺѹ ¸Ñ Ò ÃÑ¡Éì | 2 | | 1.25 |
| ºÑµÃ»ÃЪҪ¹ãºà´ÕÂÇ | 2 | | 1.25 |
| áʧÊèͧ㨠Íѹ´Ñº 1 | 2 | | 1.25 |
| gmp âç§Ò¹ à¡ÕèÂǡѺ ¡ÒüÅÔµ¢¹Á»Ñ§ | 2 | | 1.25 |
| µÅÒ´à¹×éÍâ¤ÃдѺÅèÒ§ | 2 | | 1.25 |
| ¾Ñ²¹Ò¡ÒÃà´ç¡ ¢Í§ ÊØÀÒÇ´Õ ËÒàÁ¸Õ »Õ 2532ºÃóҹءÃÁ | 2 | | 1.25 |
| ÇѤ«Õ¹ eric | 2 | | 1.25 |
| §Ò¹ÇԨѠâç¾ÂÒºÒÅÁËÒÃÒª¹¤ÃàªÕ§ãËÁèfull text | 2 | | 1.25 |
| ÇÔ¸Õ¡ÒÃãªéËéͧÊÁØ´ | 2 | | 1.25 |
| ÅѡɳеèÍÃèÒ§¡ÒÂcushing syndrome | 1 | | 0.62 |
| ¡¯¡ÃзÃǧ¤Çº¤ØÁà¡Å×ÍäÍâÍ´Õ¹ | 1 | | 0.62 |
| »ÅÑ´¡ÃзÃǧÊÒ¸ÒóÊØ¢¤¹à¡èÒ | 1 | | 0.62 |
| ÈÙ¹ÂìÇԷºÃÔ¡Òà | 1 | | 0.62 |
| ÃÙ»ÀÒ¾Á¡Ø®ÃÒª¡ØÁÒ÷ÑèÇâÅ¡ | 1 | | 0.62 |
| lysergic acid diethylamide | 1 | | 0.62 |
| thera vitae | 1 | | 0.62 |
| ËÒ¤ÇÒÁ¨ØÎÒÃì´´ÔÊ | 1 | | 0.62 |
| àÁç·â¸ÁÔÅ | 1 | | 0.62 |
| ÍÂèÒËŧàª×èÍ µ¡à»ç¹àËÂ×èÍ ¹Òâ¹ | 1 | | 0.62 |
| âËÂè§àËÔ§ ËÅÍ¡Åǧ | 1 | | 0.62 |
| á¹ÇÅÁ¾Ñ´ÊͺËÁÒ¶֧ | 1 | | 0.62 |
| ¶Ñ§àËÅç¡200ÅԵúÃèØÂÒ§ÁеÍ | 1 | | 0.62 |
| ÈعÂì·Ó¢Òà·ÕÂÁ ÀÒ¤ãµé | 1 | | 0.62 |
| ¡ÃзÃǧÊÒ¸ÒóÊØ¢ »ÃѺ°Ò¹à§Ô¹à´×͹¢éÒÃÒª¡Òà | 1 | | 0.62 |
| áËÅ觷ÕèÁҢͧÊÒÃâ»áµÊà«ÕèÂÁ¤Íàõ | 1 | | 0.62 |
| ¡ÃÁÍØ·ÂÒ¹ "ÊÑÒ³´ÒÇà·ÕÂÁ" ¹¡ | 1 | | 0.62 |
| àÊé¹àÅ×ʹᵡã¹á¡¹ÊÁͧ | 1 | | 0.62 |
| ÂÒʵÃÕ¹ÔÊÔ§àË ËÁÍÁÕ | 1 | | 0.62 |
| ÁÒµÃÒ°Ò¹¡ÒôÙáżÙé»èÇÂàºÒËÇÒ¹ | 1 | | 0.62 |
| âç¾ÂÒºÒÅàÍ¡ª¹ àºÔ¡µÃ§ ¹¹·ºØÃÕ | 1 | | 0.62 |
| ÂÒʵÃÕà¾çÀÒ¤¡ÑºÊÔÇ | 1 | | 0.62 |
| ÊÁعä¾Ã ¢Ñ´ ˹éÒ ÊØÀÒ Àà ³ì | 1 | | 0.62 |
| ÇÔ¸Õ»Ñé¹«ÙªÔ à»ç¹ÃٻǧÃÕ | 1 | | 0.62 |
| ä¢éËÇÑ´Ê໹ | 1 | | 0.62 |
| ¼ÅÔµªÒÊÁعä¾Ã¼èÒ¹ ÍÂ. | 1 | | 0.62 |
| ÂÒʵÃÕºÑÇá¡éÇ | 1 | | 0.62 |
| ä¿âºÃÁÑÂÍÑÅà¨Õ | 1 | | 0.62 |
| registry clean expert ¤×ÍÍÐäà | 1 | | 0.62 |
| swot¡ÒúԹä·Â | 1 | | 0.62 |
| thera vitae co.ltd | 1 | | 0.62 |
| ª×èÍ ©ÅÒ¡ «ÕÍÔêÇ | 1 | | 0.62 |
| national symposium on antimicrobial agent & resistance 2009 ËÃ×Í isaar 2009†| 1 | | 0.62 |
| ¿ÒÃìÁ¹éÍ¡ÅÒ§¢Ø¹à¢Ò | 1 | | 0.62 |
| ʤº.¡Ñº¡ÒäØéÁ¤Ãͧ¼ÙéºÃÔâÀ¤ | 1 | | 0.62 |
| ÂҾǡ nsaid | 1 | | 0.62 |
| àÁÅÒÁÕ¹ äÁâ¤ÃàÇ¿ | 1 | | 0.62 |
| »ÃСÒÈ ¡ÃзÃǧ ÊÒ¸ÒóÊØ¢ | 1 | | 0.62 |
,
User's Guide
˹éÒÅçÍ¡ÍÔ¹| ʶԵÔÃÒ»Õ
| ʶԵÔÃÒÂà´×͹
| ʶԵÔÃÒÂÇѹ
| ʶԵÔÃÒªÑèÇâÁ§
| Eng
Pageview 
Unique IPs 
Sessions